Results 221 to 230 of about 619,572 (261)

Incidence of Adverse Drug Events and Potential Adverse Drug Events

2021
Objectives. —To assess incidence and preventability of adverse drug events (ADEs) and potential ADEs. To analyze preventable events to develop prevention strategies. Design. —Prospective cohort study. Participants. —All 4031 adult admissions to a stratified random sample of 11 medical and surgical units in two tertiary care hospitals over a 6-month ...
openaire   +1 more source

Adverse Drug Events: Identification and Attribution

Drug Intelligence & Clinical Pharmacy, 1987
The definition of an adverse drug event should be tailored to one's purpose in examining the incident. Although the more specific of these definitions is required for scientific evaluation of the link between drug and event, other less stringent definitions are usually adequate for clinical purposes. Knowledge about the safety profile
Abraham G. Hartzema, Miquel S. Porta, Hugh H. Tilson, Audrey Smith Rogers   +3 more
openaire   +2 more sources

Mining for Adverse Drug Events on Twitter

Proceedings of the International Conference on Knowledge Discovery and Information Retrieval, 2014
At the post-marketing phase when drugs are used by large populations and for long periods, unexpected adverse events may occur altering the risk-benefit relation of drugs, sometimes requiring a regulatory action. These events at the post-marketing phase require a significant increase in health care since they result in unnecessary damage, often fatal ...
Felipe Duval, Ernesto Caffarena, Oswaldo G. Cruz, Fabrício Silva   +3 more
openaire   +1 more source

Calciphylaxis-as a drug induced adverse event

Expert Opinion on Drug Safety, 2018
Calciphylaxis is a rare but devastating disease with a mortality rate up to 50% in 1 year. It is characterized by profoundly painful ischemic skin lesions and vascular calcification that affects predominantly patients with end stage renal disease. The use of certain medications is an important modifiable risk factor in calciphylaxis and discontinuation
Portales-Castillo, Ignacio, Kroshinksy, Daniela, Malhotra, Cindy K, Culbert-Costley, Roberta, Cozzolino, Mario Gennaro, Karparis, Shelly, Halasz, Charles L, Goverman, Jeremy, Manley, Harold J, Malhotra, Rajeev, Nigwekar, Sagar U   +10 more
openaire   +2 more sources

Adverse Drug Events in Pediatric Outpatients

Ambulatory Pediatrics, 2007
To determine rates and types of adverse drug events (ADEs) in the pediatric ambulatory setting.A prospective cohort study at 6 office practices in the greater Boston area was conducted over 2-month periods. Duplicate prescription review, telephone surveys 10 days and 2 months after visit, and chart reviews were done.
Kaushal, Rainu, Goldmann, Donald A., Keohane, Carol A., Christino, Melissa, Honour, Melissa, Hale, Andrea S., Zigmont, Katherine, Lehmann, Lisa Soleymani, Perrin, James, Bates, David W.   +9 more
openaire   +4 more sources

Adverse Drug Events and Medication Safety

The Senior Care Pharmacist
Medication safety is a key tenet of geriatric pharmacotherapy. As senior care pharmacists, we spend much of our practice effort preventing and managing medication safety concerns. Embracing “Age-Friendly” practice necessitates that we develop a continuous quality improvement mindset that leads to actions that improve patient-centered safety and ...
Demetra, Antimisiaris, Patricia W, Slattum   +1 more
openaire   +2 more sources

Adverse Drug Events in Ambulatory Care

New England Journal of Medicine, 2003
Adverse events related to drugs occur frequently among inpatients, and many of these events are preventable. However, few data are available on adverse drug events among outpatients. We conducted a study to determine the rates, types, severity, and preventability of such events among outpatients and to identify preventive strategies.We performed a ...
Gandhi, Tejal, Weingart, Saul N., Borus, Joshua, Seger, Andrew, Peterson, Josh, Burdick, Elisabeth, Seger, Diane L., Small, Kirstin, Federico, Frank, Leape, Lucian, Bates, David   +10 more
openaire   +5 more sources

Design of Adverse Drug Events-Scorecards

2011
This paper presents the design of Adverse Drug Event-Scorecards. The scorecards described are innovative and novel, not having previously been reported in the literature. The Scorecards provide organizations (e.g. hospitals) with summary information about Adverse Drug Events (ADEs) using a Web-based platform.
Romaric Marcilly, Emmanuel Chazard, Marie-Catherine Beuscart-Zéphir, Werner O. Hackl, Adrian Baceanu, Andre Kushniruk, Elizabeth M. Borycki   +6 more
openaire   +3 more sources

Standardizing Drug Adverse Event Reporting Data

2013
Normalizing data in the Adverse Event Reporting System (AERS), an FDA database, would improve the mining capacity of AERS for drug safety signal detection. In this study, we aim to normalize AERS and build a publicly available normalized Adverse drug events (ADE) data source.he drug information in AERS is normalized to RxNorm, a standard terminology ...
Liwei Wang 0010, Guoqian Jiang, Dingcheng Li, Hongfang Liu   +3 more
openaire   +2 more sources

Reporting Adverse Drug Events

American Journal of Gastroenterology, 2019
Linda A, Feagins, George G, Abdelsayed, Jason, Schairer   +2 more
openaire   +2 more sources